This unique formulation, powered by our innovative sublingual base, bypasses the stomach entirely, allowing for direct absorption through the tissues under the tongueresulting in more consistent efficacy compared to standard oral options
What will I be asked to do if I take part
However, HbA1c reductionsthe key marker of long-term glucose controlare typically assessed at 36 months after starting treatment, in line with NICE guidance for monitoring type 2 diabetes medications
Tuttavia, importante sottolineare che, pur essendo un aiuto efficace, la semaglutide non sostituisce limportanza di una dieta equilibrata e uno stile di vita sano
Having moderate to severe diabetic retinopathy before starting the medication A history of poorly controlled blood sugar over many years High blood pressure that is not well managed Kidney disease or other diabetes-related complications Very rapid reduction in hemoglobin A1C levels within the first few months Rare cases of sudden, painless vision loss from optic nerve injury have been reported in people using GLP-1 receptor agonist medications
